<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The occurrence of posttransplant <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo> (PTLD) in solid organ allograft recipients can be quite varied in clinical presentation, histopathological characteristics and frequency </plain></SENT>
<SENT sid="1" pm="."><plain>A variety of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> can develop as a PTLD although some types appear infrequently and remain poorly understood in this clinical setting </plain></SENT>
<SENT sid="2" pm="."><plain>In this report, we describe two cases of Burkitt s <z:hpo ids='HP_0002665'>lymphoma</z:hpo> presenting as a PTLD following liver transplantation </plain></SENT>
<SENT sid="3" pm="."><plain>The recipients were 12 and 44 years of age and displayed gastrointestinal involvement by the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> several years following transplant </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> displayed the typical histological features of Burkitt s <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and were markedly positive for EBV </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> displayed similar immunophenotypic characteristics by flow cytometry and had rearrangements of the immunoglobulin J-H heavy chain </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> required aggressive chemotherapy and a cessation of immunosuppressive therapy </plain></SENT>
<SENT sid="7" pm="."><plain>This report demonstrates that Burkitt s type <z:hpo ids='HP_0002665'>lymphomas</z:hpo> can develop in the posttransplant setting and that these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> contain morphologic, cytofluorographic and molecular features identical to Burkitt s <z:hpo ids='HP_0002665'>lymphomas</z:hpo> that occur in non-transplant patients </plain></SENT>
<SENT sid="8" pm="."><plain>Our experience is that these PTLD- Burkitt s <z:hpo ids='HP_0002665'>lymphomas</z:hpo> behave aggressively and require intensive chemotherapeutic intervention </plain></SENT>
</text></document>